Mutual of America Capital Management LLC Grows Position in HCA Healthcare, Inc. (NYSE:HCA)

Mutual of America Capital Management LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,448 shares of the company’s stock after buying an additional 33 shares during the quarter. Mutual of America Capital Management LLC’s holdings in HCA Healthcare were worth $9,936,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Natixis Advisors LLC boosted its position in HCA Healthcare by 2.3% in the third quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock valued at $44,750,000 after buying an additional 2,459 shares during the last quarter. Mizuho Securities USA LLC increased its stake in shares of HCA Healthcare by 205.4% in the third quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company’s stock worth $18,548,000 after acquiring an additional 30,693 shares during the period. Simplify Asset Management Inc. lifted its position in HCA Healthcare by 67.1% during the third quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company’s stock valued at $956,000 after purchasing an additional 944 shares during the period. Valley Wealth Managers Inc. raised its stake in shares of HCA Healthcare by 14.4% during the 3rd quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company’s stock valued at $562,000 after buying an additional 174 shares during the last quarter. Finally, Empowered Funds LLC boosted its stake in shares of HCA Healthcare by 10.2% in the third quarter. Empowered Funds LLC now owns 21,824 shares of the company’s stock worth $8,870,000 after buying an additional 2,019 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $342.96 on Monday. HCA Healthcare, Inc. has a one year low of $238.82 and a one year high of $417.14. The company has a market cap of $86.87 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 1.32 and a beta of 1.68. The business’s 50 day moving average price is $385.11 and its 200 day moving average price is $357.92. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Analyst Ratings Changes

HCA has been the topic of several recent research reports. Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. UBS Group upped their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Barclays cut their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. KeyCorp cut their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $385.00.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.